Acetyl GLP-1 + GIP 10 mg

cetyl GLP-1 + GIP is a powerful dual-incretin peptide that combines the activity of Glucagon-Like Peptide-1 (GLP-1) and Gastric Inhibitory Polypeptide (GIP) in a single formulation. This advanced peptide is acetylated to enhance stability and bioavailability, making it ideal for in-depth metabolic and endocrine research.

GLP-1 and GIP are key regulators of insulin secretion, glucose metabolism, and appetite. Their synergistic action has gained significant attention in research related to obesity, Type 2 diabetes, and energy balance. The acetylated form helps extend half-life and improve peptide resistance to enzymatic degradation, offering more consistent results in experimental applications.

Potential Research Applications:

• Glucose Regulation – Investigating dual incretin effects on insulin secretion and blood glucose control.

• Obesity & Appetite Studies – Exploring mechanisms behind appetite suppression, satiety, and weight management.

• Insulin Sensitivity – Understanding how GLP-1 + GIP influence insulin response and pancreatic β-cell function.

• Energy Homeostasis – Studying effects on metabolism, fat storage, and energy expenditure.

• Gastrointestinal Hormone Interaction – Examining gut-brain axis signaling and hormone interactions in metabolic pathways.